APRIA INC (APR)
Common Stock
We assign a fundamental rating of 2 out of 10 to APR. APR was compared to 117 industry peers in the Health Care Providers & Services industry. APR has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, APR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
APR had positive earnings in the past year.
Each year in the past 5 years APR has been profitable.
APR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.36% | ||
| ROE | 163.17% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.65% | ||
| PM (TTM) | 5.66% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for APR has been increased compared to 1 year ago.
The debt/assets ratio for APR has been reduced compared to a year ago.
2.2 Solvency
APR has an Altman-Z score of 1.39. This is a bad value and indicates that APR is not financially healthy and even has some risk of bankruptcy.
APR has a Debt/Equity ratio of 8.58. This is a high value indicating a heavy dependency on external financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 8.58 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.39 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 1.09 indicates that APR should not have too much problems paying its short term obligations.
A Quick Ratio of 1.06 indicates that APR should not have too much problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
APR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.97%, which is quite impressive.
Measured over the past years, APR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.35% on average per year.
APR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.30%.
Measured over the past years, APR shows a small growth in Revenue. The Revenue has been growing by 1.62% on average per year.
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y-11.35%
EPS growth Q2Q-98.12%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y1.62%
Revenue growth Q2Q0.93%
3.2 Future
Based on estimates for the next years, APR will show a small growth in Earnings Per Share. The EPS will grow by 7.08% on average per year.
Based on estimates for the next years, APR will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y5.86%
EPS Next 2Y6.66%
EPS Next 3Y6.76%
EPS Next 5Y7.08%
Revenue Next Year5.14%
Revenue Next 2Y4.96%
Revenue Next 3Y4.61%
Revenue Next 5Y4.7%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.43, which indicates a rather expensive current valuation of APR.
Compared to an average S&P500 Price/Earnings ratio of 28.06, APR is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 20.24, the valuation of APR can be described as rather expensive.
APR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 20.24 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.66
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y6.76%
5. Dividend
5.1 Amount
APR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APRIA INC
NASDAQ:APR (3/28/2022, 7:26:58 PM)
After market: 37.51 +0.01 (+0.03%)37.5
+0.01 (+0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.34B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 20.24 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.66
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.36% | ||
| ROE | 163.17% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.65% | ||
| PM (TTM) | 5.66% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 8.58 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y
EPS growth Q2Q
EPS Next Y5.86%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y